REVIEW PAPER: pathology of animal models of alphavirus encephalitis.
Authors: Steele K E, Twenhafel N A
Journal: Veterinary pathology
Summary
# Editorial Summary: Pathology of Animal Models of Alphavirus Encephalitis Venezuelan, eastern, and western equine encephalitis viruses present significant threats to equine and human populations globally, yet no licensed vaccines or specific treatments currently exist, creating an urgent need for robust animal models to develop medical countermeasures. Steele and Twenhafel's 2010 review synthesises pathological findings from experimental infections in mice, nonhuman primates, and other species exposed to these alphaviruses, with particular attention to aerosol transmission routes that mirror potential bioterrorism scenarios. Disease manifestations vary considerably across animal models, though infection typically progresses to encephalitis with substantial mortality; however, the review identifies critical knowledge gaps in three key pathogenic phases: early systemic spread before neuroinvasion, the mechanisms of virus crossing the blood–brain barrier, and the specific viral and host factors determining neurological virulence. Understanding these pathogenic mechanisms at a molecular level is essential both for developing therapeutic interventions and for establishing standardised animal models suitable for regulatory approval of medical countermeasures under the FDA's Animal Rule. For equine practitioners, this work underscores the relevance of studying these viruses in horses as naturally susceptible hosts, whilst highlighting that experimental findings from laboratory models must be carefully interpreted given the substantial variability in disease expression between species.
Read the full abstract on PubMed
Practical Takeaways
- •This is a foundational review for understanding alphavirus encephalitis pathology in research contexts; direct clinical application to equine practice is limited as the focus is on biodefense research and human medical countermeasures
- •Practitioners should recognize that equine encephalitis viruses (VEEV, EEEV, WEEV) remain significant natural disease threats to horses and humans with no specific treatments available—prevention through vector control and vaccination remains paramount
- •The variability in disease expression across animal models highlights why clinical presentations in horses may differ significantly, emphasizing the need for species-specific understanding in diagnostic and therapeutic approaches
Key Findings
- •VEEV, EEEV, and WEEV cause encephalitis and death in mice, nonhuman primates, and other animal models with high variability in disease manifestations across species
- •No licensed vaccines or specific therapies currently exist for human infections with these three alphavirus species
- •Three critical pathogenic phases require better characterization: early extraneural phase, neuroinvasion process, and virus/host factors related to neurovirulence
- •Well-characterized animal models are essential for developing medical countermeasures under FDA Animal Rule regulations